Latest News about PFE
Recent news which mentions PFE
2 Biotech Stocks You Can Buy and Hold for the Next Decade
November 28, 2022
From Motley Fool
From Benzinga
From MarketWatch
Is Novavax Stock a Buy Now?
November 26, 2022
From Motley Fool
Better Dividend Stock: AbbVie or Viatris?
November 26, 2022
From Motley Fool
From Benzinga
Researchers Working On Universal mRNA-Influenza Vaccine Aiming For Baseline Immune Memory For Diverse Strains
November 25, 2022
From Benzinga
As COVID cases rise, China locks down despite criticism
November 25, 2022
Tickers
PFE
Tags
PFE
From MarketWatch
Is Now the Time for Income Investors to Buy This Big Pharma Stock?
November 24, 2022
From Motley Fool
Novavax Stock: Buy, Sell, or Hold in 2023?
November 24, 2022
From Motley Fool
From Benzinga
PFE Stock Could Be the Booster Shot Your Portfolio Needs Now
November 23, 2022
From InvestorPlace
Jim Cramer Says China's Vaccines 'Don't Work' But Xi Won't Admit It
November 22, 2022
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 22, 2022
From Benzinga
Confused about COVID boosters? Here’s what the science and the experts say about the new generation of shots.
November 22, 2022
From MarketWatch
From Benzinga
China’s three-week COVID case tally tops 253,000 and daily average is rising, government says
November 22, 2022
From MarketWatch
A Look Into Healthcare Sector Value Stocks
November 21, 2022
From Benzinga
2 Reasons to Buy Pfizer and 1 Reason to Sell
November 20, 2022
From Motley Fool
3 Unstoppable Growth Stocks to Buy and Hold
November 19, 2022
From Motley Fool
Here's What Value Stocks Can Do for a Growth Investor
November 18, 2022
From Motley Fool
Pfizer Is Worst-Performing US Large-Cap Pharma Stock This Year, Its Investment Case Is Complex Yet Rewarding
November 18, 2022
Tickers
PFE
From Benzinga
Pfizer/BioNTech's Omicron Tailored COVID-19 Vaccine Shows Improved Immune Response Against Emerging Omicron Sublineages
November 18, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
November 18, 2022
From Benzinga
Pfizer and BioNTech updated booster shows strong results against new omicron sublineages in fresh analysis of data
November 18, 2022
From MarketWatch
From Benzinga
Pfizer, BioNTech Start Work On Next-Gen COVID-19 Vaccine Candidate For Broader Protection
November 17, 2022
From Benzinga
2 Dirt Cheap Dividend Stocks to Buy Right Now
November 16, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.